Compare · AMEH vs FCN
AMEH vs FCN
Side-by-side comparison of Apollo Medical Holdings Inc. (AMEH) and FTI Consulting Inc. (FCN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMEH and FCN operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- FCN is the larger of the two at $4.78B, about 1.8x AMEH ($2.62B).
- FCN has hit the wire 17 times in the past 4 weeks while AMEH has been quiet.
- AMEH has more recent analyst coverage (9 ratings vs 2 for FCN).
- Company
- Apollo Medical Holdings Inc.
- FTI Consulting Inc.
- Price
- $40.83-2.20%
- $158.83-0.48%
- Market cap
- $2.62B
- $4.78B
- 1M return
- -
- -2.01%
- 1Y return
- -
- -0.75%
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 1999
- News (4w)
- 0
- 17
- Recent ratings
- 9
- 2
Apollo Medical Holdings Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
FTI Consulting Inc.
FTI Consulting, Inc. provides business advisory services to manage change, mitigate risk, and resolve disputes worldwide. Its Corporate Finance & Restructuring segment provides business transformation, transactions, turnaround, restructuring, and bankruptcy services. The company's Forensic and Litigation Consulting segment offers anti-corruption/anti-money laundering investigations and compliance, and data and analytics, as well as compliance, monitoring, and receivership services; cybersecurity, forensic accounting and advisory, and global risk and investigations practice; and construction solutions, dispute advisory, trial, insurance claims, health and environmental solutions, and export controls and sanctions. Its Economic Consulting segment provides financial, economic, and econometric consulting; business and expert valuation, and expert testimony services; intellectual property services; economic and statistical analyses services; services related to public policy and regulated industries, and healthcare economics and policy; international arbitration; and economic impact analysis, market modeling, and securities litigation and risk management services and other litigation services. The company's Technology segment offers e-discovery and data compliance management, managed document review, digital forensics, information governance, privacy and security, and contract intelligence services, as well as Radiance Visual Analytics software. Its Strategic Communications segment provides advice services relating to public affairs and government relations, crisis communications, corporate reputation, digital and, capital markets communications, transaction communications, and digital, analytics, and insights. The company was founded in 1982 and is headquartered in Washington, District of Columbia.
Latest AMEH
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Apollo Medical Hlgs Q4 2023 GAAP EPS $0.26 Beats $0.15 Estimate, Sales $353.04M Beat $340.61M Estimate
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Apollo Medical Hlgs's Earnings Outlook
- Jefferies Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $50
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Apollo shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $44 to $55.
- B of A Securities Upgrades Apollo Medical Hlgs to Buy, Raises Price Target to $55
- Apollo Medical upgraded by BofA Securities with a new price target
- Apollo Medical Holdings Announced That It Will Formally Change Its Name From Apollo Medical Holdings, Inc. To Astrana Health, Inc. And Will Begin Trading Under The Ticker Symbol "ASTH", Both Effective February 26, 2024
Latest FCN
- Director Boglioli Elsy Lisa covered exercise/tax liability with 138 shares, decreasing direct ownership by 3% to 5,338 units (SEC Form 4)
- Director Costamagna Claudio covered exercise/tax liability with 207 shares, decreasing direct ownership by 0.56% to 36,529 units (SEC Form 4)
- FTI Consulting Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- FTI Consulting, Inc. Announces $370.0 Million Stock Repurchase Authorization
- Director Zelenka Janet was granted 1,616 shares, increasing direct ownership by 89% to 3,432 units (SEC Form 4)
- Director Steigerwalt Eric T was granted 1,616 shares, increasing direct ownership by 89% to 3,432 units (SEC Form 4)
- Director Boglioli Elsy Lisa was granted 1,616 shares, increasing direct ownership by 42% to 5,476 units (SEC Form 4)
- Director Robinson Stephen C was granted 1,616 shares, increasing direct ownership by 28% to 7,428 units (SEC Form 4)
- Director Seeger Laureen was granted 1,987 shares, increasing direct ownership by 11% to 19,636 units (SEC Form 4)
- Director Fanandakis Nicholas C was granted 1,616 shares, increasing direct ownership by 10% to 17,753 units (SEC Form 4)